Current role
Samuel Agresta
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Foghorn Therapeutics Inc. (FHTX)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Foghorn Therapeutics Inc. (FHTX) | Chief Medical Officer | $428,500 | $1,809,604 |
| 2020 | Foghorn Therapeutics Inc. (FHTX) | Chief Medical Officer | $412,000 | $1,053,797 |
| 2019 | Foghorn Therapeutics Inc. (FHTX) | Chief Medical Officer | $116,667 | $1,202,274 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.